Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study

被引:0
|
作者
Gooding, Diane Carol [1 ,2 ,3 ]
Van Hulle, Carol A. [3 ,4 ]
Zuelsdorff, Megan [5 ]
Lewis, Jordan P. [6 ]
Carter, Fabu P. [4 ]
Salazar, Hector [3 ,4 ]
Bouges, Shenikqua [3 ,4 ,7 ]
James, Taryn T. [3 ,4 ]
Gee, Alexander [8 ]
Gleason, Carey E. [3 ,4 ,9 ]
机构
[1] UW Madison, Dept Psychol, Madison, WI USA
[2] UW Madison, Sch Med & Publ Hlth, Dept Psychiat, Madison, WI USA
[3] UW Madison, Sch Med & Publ Hlth, Dept Med, Geriatr & Gerontol, Madison, WI USA
[4] UW Madison, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA
[5] UW Madison, Sch Nursing, Madison, WI USA
[6] Univ Minnesota, Med Sch, Duluth Campus, Duluth, MN USA
[7] Middleton Mem Hosp, Madison VA GRECC, Madison, WI USA
[8] Nehemiah Ctr Urban Leadership Dev, Madison, WI USA
[9] UW Madison, Wisconsin Alzheimers Inst, Sch Med & Publ Hlth, Madison, WI USA
关键词
Alzheimer's disease; biomarker testing; blood-based biomarkers; brain scanning; lumbar puncture; race/ethnicity; research attitudes; research participation; testing willingness; BIOMEDICAL-RESEARCH; DEMENTIA; HEALTH;
D O I
10.1177/13872877241307255
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Past research suggests that ethnoracialized groups differ in their willingness to engage in preclinical Alzheimer's disease (AD) research overall. Studies indicated that participation willingness was affected by attitudes toward research and perceived invasiveness of biomarker collection techniques. However, comparative quantitative studies are few, and minoritized groups are under-included. Objective: In a cross-sectional online survey, we sought to explore community-based adults' willingness to engage in preclinical AD biomarker testing, comparing their attitudes about research and different types of biomarker procedures. Methods: We conducted an online survey with a diverse group of participants. African American (AA), American Indian/Alaska Native (AI/AN), Latinx (LTX), and Non-Hispanic White (NHW) adults aged 26-90 were asked about their research attitudes, biomarkers, and willingness to participate in specific biomarker test procedures (i.e., brain imaging via PET scanning, blood draws, and cerebrospinal fluid collection by lumbar puncture). We also assessed participants' perceived safety, burden, and distress for each of the three biomarker collection methods. To understand the association between research willingness and ethnoracial identity, we ran linear regression models for each procedure, adjusting for age, gender, educational attainment, and attitudes toward research. Results: The AA group expressed greater willingness to engage in biomarker testing involving blood draws than the NHW group. The AI/AN group was significantly less willing to undergo lumbar puncture than the NHW group; this difference remained after adjusting for various sociodemographic factors and research attitudes. Conclusions: Respondents' willingness to engage in preclinical AD biomarker research was affected by their perceptions about the testing collection procedure.
引用
收藏
页码:865 / 878
页数:14
相关论文
共 50 条
  • [31] HFE variants, APOE and Alzheimer's disease: Findings from the population-based Rotterdam Study
    Alizadeh, B. Z.
    Njajou, O. T.
    Millan, M. R.
    Hofman, A.
    Breteler, M. M.
    van Duijn, C. M.
    NEUROBIOLOGY OF AGING, 2009, 30 (02) : 330 - 332
  • [32] Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
    Buckley, Rachel F.
    Mormino, Elizabeth C.
    Amariglio, Rebecca E.
    Properzi, Michael J.
    Rabin, Jennifer S.
    Lim, Yen Ying
    Papp, Kathryn V.
    Jacobs, Heidi I. L.
    Burnham, Samantha
    Hanseeuw, Bernard J.
    Dore, Vincent
    Dobson, Annette
    Masters, Colin L.
    Waller, Michael
    Rowe, Christopher C.
    Maruff, Paul
    Donohue, Michael C.
    Rentz, Dorene M.
    Kirn, Dylan
    Hedden, Trey
    Chhatwal, Jasmeer
    Schultz, Aaron P.
    Johnson, Keith A.
    Villemagne, Victor L.
    Sperling, Reisa A.
    ALZHEIMERS & DEMENTIA, 2018, 14 (09) : 1193 - 1203
  • [33] Elevated C-Reactive Protein in Alzheimer's Disease Without Depression in Older Adults: Findings From the Health and Retirement Study
    Natale, Ginny
    Clouston, Sean A. P.
    Smith, Dylan M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2022, 77 (04): : 673 - 682
  • [34] Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study
    Ball, Sarah L.
    Holland, Anthony J.
    Hon, Johnny
    Huppert, Felicia A.
    Treppner, Peter
    Watson, Peter C.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (07) : 661 - 673
  • [35] Computerized cognitive testing to capture cognitive decline in Alzheimer's disease: Longitudinal findings from the ARMADA study
    Jutten, Roos J.
    Ho, Emily H.
    Karpouzian-Rogers, Tatiana
    van Hulle, Carol
    Carlsson, Cynthia
    Dodge, Hiroko H.
    Nowinski, Cindy J.
    Gershon, Richard
    Weintraub, Sandra
    Rentz, Dorene M.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2025, 17 (01)
  • [36] Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study
    Sheng, Can
    Yang, Kun
    He, Beiqi
    Du, Wenying
    Cai, Yanning
    Han, Ying
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [37] What Can We Learn About the Concept of Meaning in Life from Older Adults with Alzheimer's Disease? A Directed Content Analysis Study
    Dewitte, Laura
    Schellekens, Tine
    Steger, Michael F.
    Martela, Frank
    Vanhooren, Siebrecht
    Vandenbulcke, Mathieu
    Dezutter, Jessie
    JOURNAL OF HAPPINESS STUDIES, 2021, 22 (07) : 2845 - 2871
  • [38] Can impairment in memory, language and executive functions predict neuropsychiatric symptoms in Alzheimer's disease (AD)? Findings from a cross-sectional study
    Maria Garcia-Alberca, Jose
    Pablo Lara, Jose
    Luis Berthier, Marcelo
    Cruz, Belen
    Angel Barbancho, Miguel
    Green, Cristina
    Gonzalez-Baron, Salvador
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2011, 52 (03) : 264 - 269
  • [39] Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study
    Guan, Yue
    Roter, Debra L.
    Erby, Lori H.
    Wolff, Jennifer L.
    Gitlin, Laura N.
    Roberts, J. Scott
    Green, Robert C.
    Christensen, Kurt D.
    PATIENT EDUCATION AND COUNSELING, 2017, 100 (05) : 927 - 935
  • [40] CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease
    Lizama, Britney N.
    Williams, Claire
    North, Hilary A.
    Pandey, Kiran
    Duong, Duc
    Di Caro, Valentina
    Mecca, Adam P.
    Blennow, Kaj
    Zetterberg, Henrik
    Levey, Allan I.
    Grundman, Michael
    van Dyck, Christopher H.
    Caggiano, Anthony O.
    Seyfried, Nicholas T.
    Hamby, Mary E.
    ALZHEIMERS & DEMENTIA, 2024, 20 (10) : 6860 - 6880